Comparative clinical reliability of fasting plasma glucose and glycosylated hemoglobin in non-insulin-dependent diabetes mellitus

R. E. Pecoraro, T. D. Koepsell, M. S. Chen, B. A. Lipsky, D. W. Belcher, Thomas Inui

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Because accurate determination of glycosylated hemoglobin (GHb) is difficult and relatively expensive in comparison with the modest cost and ready availability for tests of fasting plasma glucose (FPG), we examined the reliability of repeated measurements of FPG and GHb in typical diabetic outpatients taken in the usual clinical setting. We determined FPG and GHb concurrently on three separate occasions spanning 4 wk in 41 patients with non-insulin-dependent diabetes mellitus (NIDDM) and, for contrast, 5 with insulin-dependent diabetes mellitus (IDDM). Most of the NIDDM subjects were obese, with initial FPG levels ranging from 93 to 355 mg/dl. The reliability of each test was estimated by calculating two measures: the intraclass correlation coefficient (ρ(I)) and the coefficient of variation (CV) for the repeated test values. For NIDDM patients treated with diet or oral hypoglycemic agents (OHA), ρ(I) for FPG, log(FPG), and GHb were very similar. For insulin-treated NIDDM patients, ρ(I) for FPG was somewhat lower than the coefficient in other treatment groups, and the reliability of FPG by this measure did not match the reliability of GHb within the limits of statistical significance. By analyzing the CV of test values repeated within subjects, the reliability of FPG did not differ from GHb in any of the NIDDM treatment groups. Although patients were recruited sequentially to minimize sample selection bias, caution must be exercised in the interpretation of the statistical analyses of reliability with either ρ(I) or CV due to limitations imposed by small sample size. As anticipated, the reliability of FPG measurements among IDDM subjects was substantially lower than the test's reliability in NIDDM, whereas GHb appeared to show comparable reliability in both types of diabetes. We conclude that FPG is as reliable as GHb to indicate glycemic status in clinically stable outpatients with NIDDM treated with diet or oral agents. This contrasts with IDDM, in which the reliability of GHb is superior and FPG is unreliable.

Original languageEnglish (US)
Pages (from-to)370-375
Number of pages6
JournalDiabetes Care
Volume9
Issue number4
StatePublished - 1986
Externally publishedYes

Fingerprint

Glycosylated Hemoglobin A
Type 2 Diabetes Mellitus
Fasting
Glucose
Type 1 Diabetes Mellitus
Outpatients
Diet
Selection Bias
Hypoglycemic Agents
Sample Size
Insulin

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Pecoraro, R. E., Koepsell, T. D., Chen, M. S., Lipsky, B. A., Belcher, D. W., & Inui, T. (1986). Comparative clinical reliability of fasting plasma glucose and glycosylated hemoglobin in non-insulin-dependent diabetes mellitus. Diabetes Care, 9(4), 370-375.

Comparative clinical reliability of fasting plasma glucose and glycosylated hemoglobin in non-insulin-dependent diabetes mellitus. / Pecoraro, R. E.; Koepsell, T. D.; Chen, M. S.; Lipsky, B. A.; Belcher, D. W.; Inui, Thomas.

In: Diabetes Care, Vol. 9, No. 4, 1986, p. 370-375.

Research output: Contribution to journalArticle

Pecoraro, R. E. ; Koepsell, T. D. ; Chen, M. S. ; Lipsky, B. A. ; Belcher, D. W. ; Inui, Thomas. / Comparative clinical reliability of fasting plasma glucose and glycosylated hemoglobin in non-insulin-dependent diabetes mellitus. In: Diabetes Care. 1986 ; Vol. 9, No. 4. pp. 370-375.
@article{27efc2a8151a4260ae419179f2cea816,
title = "Comparative clinical reliability of fasting plasma glucose and glycosylated hemoglobin in non-insulin-dependent diabetes mellitus",
abstract = "Because accurate determination of glycosylated hemoglobin (GHb) is difficult and relatively expensive in comparison with the modest cost and ready availability for tests of fasting plasma glucose (FPG), we examined the reliability of repeated measurements of FPG and GHb in typical diabetic outpatients taken in the usual clinical setting. We determined FPG and GHb concurrently on three separate occasions spanning 4 wk in 41 patients with non-insulin-dependent diabetes mellitus (NIDDM) and, for contrast, 5 with insulin-dependent diabetes mellitus (IDDM). Most of the NIDDM subjects were obese, with initial FPG levels ranging from 93 to 355 mg/dl. The reliability of each test was estimated by calculating two measures: the intraclass correlation coefficient (ρ(I)) and the coefficient of variation (CV) for the repeated test values. For NIDDM patients treated with diet or oral hypoglycemic agents (OHA), ρ(I) for FPG, log(FPG), and GHb were very similar. For insulin-treated NIDDM patients, ρ(I) for FPG was somewhat lower than the coefficient in other treatment groups, and the reliability of FPG by this measure did not match the reliability of GHb within the limits of statistical significance. By analyzing the CV of test values repeated within subjects, the reliability of FPG did not differ from GHb in any of the NIDDM treatment groups. Although patients were recruited sequentially to minimize sample selection bias, caution must be exercised in the interpretation of the statistical analyses of reliability with either ρ(I) or CV due to limitations imposed by small sample size. As anticipated, the reliability of FPG measurements among IDDM subjects was substantially lower than the test's reliability in NIDDM, whereas GHb appeared to show comparable reliability in both types of diabetes. We conclude that FPG is as reliable as GHb to indicate glycemic status in clinically stable outpatients with NIDDM treated with diet or oral agents. This contrasts with IDDM, in which the reliability of GHb is superior and FPG is unreliable.",
author = "Pecoraro, {R. E.} and Koepsell, {T. D.} and Chen, {M. S.} and Lipsky, {B. A.} and Belcher, {D. W.} and Thomas Inui",
year = "1986",
language = "English (US)",
volume = "9",
pages = "370--375",
journal = "Diabetes Care",
issn = "1935-5548",
publisher = "American Diabetes Association Inc.",
number = "4",

}

TY - JOUR

T1 - Comparative clinical reliability of fasting plasma glucose and glycosylated hemoglobin in non-insulin-dependent diabetes mellitus

AU - Pecoraro, R. E.

AU - Koepsell, T. D.

AU - Chen, M. S.

AU - Lipsky, B. A.

AU - Belcher, D. W.

AU - Inui, Thomas

PY - 1986

Y1 - 1986

N2 - Because accurate determination of glycosylated hemoglobin (GHb) is difficult and relatively expensive in comparison with the modest cost and ready availability for tests of fasting plasma glucose (FPG), we examined the reliability of repeated measurements of FPG and GHb in typical diabetic outpatients taken in the usual clinical setting. We determined FPG and GHb concurrently on three separate occasions spanning 4 wk in 41 patients with non-insulin-dependent diabetes mellitus (NIDDM) and, for contrast, 5 with insulin-dependent diabetes mellitus (IDDM). Most of the NIDDM subjects were obese, with initial FPG levels ranging from 93 to 355 mg/dl. The reliability of each test was estimated by calculating two measures: the intraclass correlation coefficient (ρ(I)) and the coefficient of variation (CV) for the repeated test values. For NIDDM patients treated with diet or oral hypoglycemic agents (OHA), ρ(I) for FPG, log(FPG), and GHb were very similar. For insulin-treated NIDDM patients, ρ(I) for FPG was somewhat lower than the coefficient in other treatment groups, and the reliability of FPG by this measure did not match the reliability of GHb within the limits of statistical significance. By analyzing the CV of test values repeated within subjects, the reliability of FPG did not differ from GHb in any of the NIDDM treatment groups. Although patients were recruited sequentially to minimize sample selection bias, caution must be exercised in the interpretation of the statistical analyses of reliability with either ρ(I) or CV due to limitations imposed by small sample size. As anticipated, the reliability of FPG measurements among IDDM subjects was substantially lower than the test's reliability in NIDDM, whereas GHb appeared to show comparable reliability in both types of diabetes. We conclude that FPG is as reliable as GHb to indicate glycemic status in clinically stable outpatients with NIDDM treated with diet or oral agents. This contrasts with IDDM, in which the reliability of GHb is superior and FPG is unreliable.

AB - Because accurate determination of glycosylated hemoglobin (GHb) is difficult and relatively expensive in comparison with the modest cost and ready availability for tests of fasting plasma glucose (FPG), we examined the reliability of repeated measurements of FPG and GHb in typical diabetic outpatients taken in the usual clinical setting. We determined FPG and GHb concurrently on three separate occasions spanning 4 wk in 41 patients with non-insulin-dependent diabetes mellitus (NIDDM) and, for contrast, 5 with insulin-dependent diabetes mellitus (IDDM). Most of the NIDDM subjects were obese, with initial FPG levels ranging from 93 to 355 mg/dl. The reliability of each test was estimated by calculating two measures: the intraclass correlation coefficient (ρ(I)) and the coefficient of variation (CV) for the repeated test values. For NIDDM patients treated with diet or oral hypoglycemic agents (OHA), ρ(I) for FPG, log(FPG), and GHb were very similar. For insulin-treated NIDDM patients, ρ(I) for FPG was somewhat lower than the coefficient in other treatment groups, and the reliability of FPG by this measure did not match the reliability of GHb within the limits of statistical significance. By analyzing the CV of test values repeated within subjects, the reliability of FPG did not differ from GHb in any of the NIDDM treatment groups. Although patients were recruited sequentially to minimize sample selection bias, caution must be exercised in the interpretation of the statistical analyses of reliability with either ρ(I) or CV due to limitations imposed by small sample size. As anticipated, the reliability of FPG measurements among IDDM subjects was substantially lower than the test's reliability in NIDDM, whereas GHb appeared to show comparable reliability in both types of diabetes. We conclude that FPG is as reliable as GHb to indicate glycemic status in clinically stable outpatients with NIDDM treated with diet or oral agents. This contrasts with IDDM, in which the reliability of GHb is superior and FPG is unreliable.

UR - http://www.scopus.com/inward/record.url?scp=0022516177&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022516177&partnerID=8YFLogxK

M3 - Article

C2 - 3743312

AN - SCOPUS:0022516177

VL - 9

SP - 370

EP - 375

JO - Diabetes Care

JF - Diabetes Care

SN - 1935-5548

IS - 4

ER -